Abstract
Objectives: We investigated the impact of serum sex hormone-binding globulin (SHBG) on thrombin generation (TG) in women according to hormonal contraception.
Patients and methods: A cross-sectional study of SHBG and TG measured via calibrated automated thrombography was conducted in 150 healthy women, including 75 users of combined oral contraceptives (COC), 22 users of progestin-only contraceptives (POC) and 53 nonusers.
Results: COC but not POC-users had significantly higher SHBG levels compared with nonusers. In hormonal contraceptive users, SHBG was positively associated with both activated protein C (APC) resistance and baseline TG, and protein S and prothrombin were important mediators.
Conclusion: These data provide further evidence that SHBG may be used as a biomarker in assessing prothrombotic profile of hormonal contraception.
Original language | English |
---|---|
Pages (from-to) | 81-85 |
Number of pages | 5 |
Journal | Biomarkers |
Volume | 22 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2017 |
Keywords
- Biomarkers
- hemostasis
- prothrombotic
- PROGESTIN-ONLY CONTRACEPTION
- COMBINED ORAL-CONTRACEPTIVES
- PROTEIN-C RESISTANCE
- VENOUS THROMBOEMBOLISM
- SURROGATE MARKER
- RISK
- PLASMA
- METAANALYSIS
- COAGULATION
- THERAPY